- Home
- BWBBP vs LSB Comparison
BWBBP vs LSB Comparison
Compare BWBBP & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWBBP
- LSB
- Stock Information
- Founded
- BWBBP N/A
- LSB 2002
- Country
- BWBBP United States
- LSB China
- Employees
- BWBBP 255
- LSB N/A
- Industry
- BWBBP Major Banks
- LSB
- Sector
- BWBBP Finance
- LSB
- Exchange
- BWBBP Nasdaq
- LSB NYSE
- Market Cap
- BWBBP N/A
- LSB 72.7M
- IPO Year
- BWBBP N/A
- LSB N/A
- Fundamental
- Price
- BWBBP $20.31
- LSB $3.78
- Analyst Decision
- BWBBP
- LSB
- Analyst Count
- BWBBP 0
- LSB 0
- Target Price
- BWBBP N/A
- LSB N/A
- AVG Volume (30 Days)
- BWBBP N/A
- LSB 128.0K
- Earning Date
- BWBBP N/A
- LSB 10-18-2024
- Dividend Yield
- BWBBP N/A
- LSB N/A
- EPS Growth
- BWBBP N/A
- LSB N/A
- EPS
- BWBBP N/A
- LSB N/A
- Revenue
- BWBBP N/A
- LSB $79,415,311.00
- Revenue This Year
- BWBBP N/A
- LSB $39.33
- Revenue Next Year
- BWBBP N/A
- LSB $75.61
- P/E Ratio
- BWBBP N/A
- LSB N/A
- Revenue Growth
- BWBBP N/A
- LSB N/A
- 52 Week Low
- BWBBP N/A
- LSB $3.20
- 52 Week High
- BWBBP N/A
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- BWBBP 54.90
- LSB 33.55
- Support Level
- BWBBP $19.90
- LSB $3.20
- Resistance Level
- BWBBP $21.28
- LSB $4.14
- Average True Range (ATR)
- BWBBP 0.72
- LSB 0.74
- MACD
- BWBBP -0.03
- LSB -0.49
- Stochastic Oscillator
- BWBBP 52.18
- LSB 10.74
About BWBBP Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
Bridgewater Bancshares Inc offers retail and commercial loan and deposit services to customers within the Minneapolis-St. Paul-Bloomington, MN-WI Metropolitan Statistical Area. The company engages in providing a wide range of deposit and lending products. Its products and services include commercial deposits, loans, online business services, credit card, mobile banking, and remote deposit services.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.